The data-sharing platform is designed to make use of the blood glucose data produced by Dexcom’s CGM systems. Companies, including One Drop, have begun accessing the API and others in the U.S. can register online, the company said.
“In launching this developer platform, Dexcom combines our CGM data expertise with the creativity of the developer ecosystem to enable new solutions and business models in the treatment and management of diabetes,” Annika Jimenez, SVP of data, said in prepared remarks. “Dexcom believes in data mobility and customer choice. It also believes that the API opens up opportunities to drive Dexcom CGM data into the heart of new digital solutions for payers, providers, and most importantly people with diabetes.”
“Diabetes is a data-driven disease,” One Drop founder & CEO Jeff Dachis added. “By combining Dexcom data with One Drop’s ability to connect users, coaches and diabetes peers, this partnership will help drive innovation and will bring about more affordable, accessible, scalable, and effective solutions. It’s a big win for people with diabetes.”
“Dexcom has always been a pioneer in diabetes technology,” Dexcom president & CEO Kevin Sayer said. “Now we are extending our thought leadership into the data our device generates by enabling broad collaboration with digital health partners.”
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.